Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
National Inst. of Pharma Education and Research (NIPER) MMP9 compound 10 g
- Development stage
- Preclinical
- Lead developer
- National Institute of Pharmaceutical Education and Research
01
Overview
National Inst. of Pharma Education and Research (NIPER) MMP9 compound 10 g: sourced facts only. name: "Target-based study for compound 10 g revealed excellent inhibition of MMP9, as evidenced by Western blotting, Immunofluorescence study and MMP9 enzyme inhibition assay." [PMID:40716158]; target: "Target-based study for compound 10 g revealed excellent inhibition of MMP9, as evidenced by Western blotting, Immunofluorescence study and MMP9 enzyme inhibition assay." [PMID:40716158]; developer: "Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037, India." [PMID:40716158]; stage: "Among them, compound 10 g was found to be 16-fold selective towards the HCT-116 cancer cell line with an IC50 value of 1.54 ± 0.06 μM compared to a non-cancerous cell line, i.e., HEK293." [PMID:40716158]
02
Targets
MMP9 (Matrix metalloproteinase-9)
Beyond the preview
Go deeper on National Inst. of Pharma Education and Research (NIPER) MMP9 compound 10 g.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on National Inst. of Pharma Education and Research (NIPER) MMP9 compound 10 g.